{"database": "lobbying", "table": "lobbying_activities", "rows": [[1300531, "0b0fe808-c8ff-47a5-947f-f783fc250a53", "Q3", "MEHLMAN CONSULTING, INC.", 284950, "NATIONAL VENTURE CAPITAL ASSOCIATION", 2012, "third_quarter", "MED", "FDA reform:  Changes to PDUFA (Prescription Drug User Fee Act) and MDUFA (Medical Device User Fee Act) programs.\nH.R. 4132, Faster Access to Specialized Treatments (FAST) Act; S. 2113, Transforming the Regulatory Environment to Accelerate Access to Treatments (TREAT) Act; H.R. 2182, Generating Antibiotic Incentives Now (GAIN) Act of 2011; S. 2236, Advancing Breakthrough Therapies for Patients Act of 2012  (See continuation page) H.R. 5651, Food and Drug Administration Reform Act of 2012.\nS. 3187, Food and Drug Administration Safety and Innovation Act.  (Became Public Law 112-144)", "Executive Office of the President (EOP),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of", 60000, null, 0, 0, "2012-10-16T13:02:38.363000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1300531"], "units": {}, "query_ms": 63.86547500733286, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}